Publication | Open Access

Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial

VaccinationVaccine SafetyVaccinologyVaccine DevelopmentImmunologyVaccine TestingVirologyVaccine EfficacyInfection ControlMedicineVaccine ResearchInactivated Virus VaccineCovid-19